Allakos Stock Today
| ALLK Stock | USD 1.06 0.01 0.95% |
Performance0 of 100
| Odds Of DistressOver 80
|
Allakos is selling for 1.06 as of the 19th of April 2024. This is a 0.95% increase since the beginning of the trading day. The stock's last reported lowest price was 1.03. Allakos has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Allakos are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 20th of March 2024 and ending today, the 19th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 19th of July 2018 | Category Healthcare | Classification Health Care |
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company was incorporated in 2012 and is headquartered in Redwood City, California. The company has 87.87 M outstanding shares of which 5.56 M shares are presently shorted by private and institutional investors with about 8.67 trading days to cover. More on Allakos
Follow Valuation Options Odds of Bankruptcy
Financial Report 14th of May 2024
Allakos Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Allakos' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Allakos or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO, Director | Robert Alexander | |||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Allakos report their recommendations after researching Allakos' financial statements, talking to executives and customers, or listening in on Allakos' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Allakos. The Allakos consensus assessment is calculated by taking the average forecast from all of the analysts covering Allakos. | ||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators related to Allakos' liquidity, profitability, solvency, and operating efficiency, Allakos is not in a good financial situation at this time. It has a very high odds of going through financial crisis in May. Financial strength of Allakos is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||
Allakos' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Allakos' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Allakos' financial leverage. It provides some insight into what part of Allakos' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||
Allakos (ALLK) is traded on NASDAQ Exchange in USA. It is located in 825 Industrial Road, San Carlos, CA, United States, 94070 and employs 131 people. Allakos is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 93.15 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Allakos's market, we take the total number of its shares issued and multiply it by Allakos's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Allakos conducts business under Biotechnology sector and is part of Health Care industry. The entity has 87.87 M outstanding shares of which 5.56 M shares are presently shorted by private and institutional investors with about 8.67 trading days to cover.
Allakos currently holds about 212.44 M in cash with (116.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.87, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Allakos Probability Of Bankruptcy
Ownership AllocationAllakos holds a total of 87.87 Million outstanding shares. The majority of Allakos outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Allakos to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Allakos. Please pay attention to any change in the institutional holdings of Allakos as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Allakos Ownership Details
Allakos Stock Price Odds Analysis
Proceeding from a normal probability distribution, the odds of Allakos jumping above the current price in 90 days from now is about 85.12%. The Allakos probability density function shows the probability of Allakos stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Allakos has a beta of 0.929. This suggests Allakos market returns are very sensitive to returns on the market. As the market goes up or down, Allakos is expected to follow. Additionally, allakos has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Allakos to move above the current price in 90 days from now is about 85.12 (This Allakos probability density function shows the probability of Allakos Stock to fall within a particular range of prices over 90 days) .
Allakos Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Allakos that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Allakos' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Allakos' value.| Instituion | Recorded On | Shares | |
| Logos Global Management Lp | 2023-12-31 | 2.9 M | |
| Deep Track Capital, Lp | 2023-12-31 | 2.5 M | |
| Fmr Inc | 2023-12-31 | 2.1 M | |
| Geode Capital Management, Llc | 2023-12-31 | 1.6 M | |
| State Street Corporation | 2023-12-31 | 1.4 M | |
| Millennium Management Llc | 2023-12-31 | 961.7 K | |
| Sectoral Asset Management Inc | 2023-12-31 | 752.4 K | |
| Vontobel Holding Ltd. | 2023-12-31 | 752.4 K | |
| Ecor1 Capital, Llc | 2023-12-31 | 748.9 K | |
| Bvf Inc | 2023-09-30 | 8.6 M | |
| T. Rowe Price Associates, Inc. | 2023-12-31 | 7.9 M |
Allakos Historical Income Statement
Allakos Income Statement is one of the three primary financial statements used for reporting Allakos's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Allakos revenue and expense. Allakos Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Allakos' Net Interest Income is quite stable compared to the past year. Interest Income is expected to rise to about 11.3 M this year, although the value of Selling General Administrative will most likely fall to about 38.1 M. View More FundamentalsAllakos Stock Against Markets
Picking the right benchmark for Allakos stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Allakos stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Allakos is critical whether you are bullish or bearish towards Allakos at a given time. Please also check how Allakos' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Allakos without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Latest Portfolios Now
Latest PortfoliosQuick portfolio dashboard that showcases your latest portfolios |
| All Next | Launch Module |
Allakos Corporate Directors
Allakos corporate directors refer to members of an Allakos board of directors. The board of directors generally takes responsibility for the Allakos' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Allakos' board members must vote for the resolution. The Allakos board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Steven James | Independent Director | Profile | |
| Paul Walker | Independent Director | Profile | |
| Robert Andreatta | Independent Director | Profile | |
| John McKearn | Director | Profile |
How to buy Allakos Stock?
Before investing in Allakos, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Allakos. To buy Allakos stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Allakos. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Allakos stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Allakos stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Allakos stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Allakos, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Allakos Stock please use our How to Invest in Allakos guide.
Already Invested in Allakos?
The danger of trading Allakos is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Allakos is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Allakos. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Allakos is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Allakos is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Allakos Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Allakos Stock. Highlighted below are key reports to facilitate an investment decision about Allakos Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Allakos. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Allakos Stock please use our How to buy in Allakos Stock guide.You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Complementary Tools for Allakos Stock analysis
When running Allakos' price analysis, check to measure Allakos' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Allakos is operating at the current time. Most of Allakos' value examination focuses on studying past and present price action to predict the probability of Allakos' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Allakos' price. Additionally, you may evaluate how the addition of Allakos to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
Is Allakos' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Allakos. If investors know Allakos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Allakos listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.14) | Return On Assets (0.39) | Return On Equity (0.78) |
The market value of Allakos is measured differently than its book value, which is the value of Allakos that is recorded on the company's balance sheet. Investors also form their own opinion of Allakos' value that differs from its market value or its book value, called intrinsic value, which is Allakos' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Allakos' market value can be influenced by many factors that don't directly affect Allakos' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Allakos' value and its price as these two are different measures arrived at by different means. Investors typically determine if Allakos is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Allakos' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.